 |
India cancer ruling opens door for cheaper drugsIndia's move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, in a major blow to global pharmaceutical firms, experts say. On Monday, the Indian Patent Offi More… |
Friday 3 May 2024
